Specialty code 1835P2201X · San Rafael, CA
NPI
1568828390
Since 2016
Specialty
Specialty code 1835P2201X
Code 1835P2201X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
100 Smith Ranch Rd, Kaiser Permanente
San Rafael, CA, 94903
Phone (415) 492-6360
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$352K
1,998 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Ali Azarpira prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 575 prescriptions and refills. In total Ali Azarpira wrote 1,998 Medicare prescriptions that cost $352K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-22.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 575 | 592 | 274 | $9,404 |
| Breyna Budesonide/Formoterol Fumarate | 487 | 559 | 188 | $152K |
| Alvesco Ciclesonide | 310 | 520 | 108 | $57K |
| Montelukast Sodium Generic | 220 | 733 | 81 | $2,567 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 176 | 502 | 67 | $51K |
| Ultra-Fine Nano Pen Needle Pen Needle, Diabetic | 36 | 115 | 16 | $1,418 |
| Ozempic Semaglutide | 22 | 26 | Under 11 | $19K |
| Advair Hfa Fluticasone Propion/Salmeterol | 19 | 51 | Under 11 | $19K |
| Metformin Hcl Er Metformin Hcl | 17 | 50 | Under 11 | $152 |
| Victoza 2-Pak Liraglutide | 15 | 18 | Under 11 | $12K |
| Veo Insulin Syringe Syrge-Ndl,ins 0.3 Ml Half Mark | 13 | 43 | Under 11 | $312 |
| Humulin 70-30 Insulin Nph Hum/Reg Insulin Hm | 12 | 34 | Under 11 | $1,393 |
Brand drugs: 1,021 claims; generic drugs: 918 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Ali Azarpira were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.